Cancer Synoptic Reporting Project Group

Space shortcuts

Page tree

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Cancer Synoptic Reporting Project Group

24 January 2022 at 17:30 UTC

Attendees Scott Campbell Ian Green Paul Seegers Stefan Dubois Suzanne Santamaria Nicola Ingram Keng-Ling Wallin@laszlo Daniel Karlsson Thomas Ruediger. David Kwan Monica de Baca

Elaine Wooler Raj Dash


Zoom - https://snomed.zoom.us/my/pathologycrg


Meeting Recording (GoogleDrive)

https://drive.google.com/file/d/14dkEwspPXIqEoSZNcg6XW66xvRkLYK3v/view?usp=sharing


Discussion items

ItemDescriptionOwnerNotesAction
1IHC

Scott Campbell

  1. Focus on synoptic reporting uses.
  2. Examples:
    1. Breast cancer her2 from breast tissue
    2. breast cancer her2 from lymph node
    3. breast cancer her2 from any tissue

a. her2 in breast tissue


b. her2 in breast cancer from lymph node


c. her2 in breast cancer from any tissue site specimen

2Treatment effect

Scott Campbell

Continue discussion:

What are we measuring when assessing "treatment effect"?  

Is this a histologic change?  Viability of tumor cells?

  1. Primary site
  2. Lymph node
Briefly discussed, but general comments confer that this is a histologic feature property of measure.  Will address and confirm at next work group meeting

Did not discuss
3Lymph nodes

Scott Campbell

Stefan Dubois

  1. Discuss approach to lymph node body structures and differences in naming/locations (example AJCC esophageal cancer vs. JES esophageal cancer)

2. Management of observables for lymph node involvement.  Example: 

Great discussion.  Assume site specific where clinically called for...use reference materials if provided.
4AJCC update?

Jim Case

Any updates that can be shared?

Meeting Files

  File Modified
No files shared here yet.




Previous Meetings

TitleCreatorModified
No content found.

  • No labels